Literature DB >> 20014840

Astatine standard redox potentials and speciation in acidic medium.

J Champion1, C Alliot, E Renault, B M Mokili, M Chérel, N Galland, G Montavon.   

Abstract

A combined experimental and theoretical approach is used to define astatine (At) speciation in acidic aqueous solution and to answer the two main questions raised from literature data: does At(0) exist in aqueous solution and what is the chemical form of At(+III), if it exists. The experimental approach considers that a given species is characterized by its distribution coefficient (D) experimentally determined in a biphasic system. The change in speciation arising from a change in experimental conditions is observed by a change in D value. The theoretical approach involves quasi-relativistic quantum chemistry calculations. The results show that At at the oxidation state 0 cannot exist in aqueous solution. The three oxidation states present in the range of water stability are At(-I), At(+I), and At(+III) and exist as At(-), At(+), and AtO(+), respectively, in the 1-2 pH range. The standard redox potentials of the At(+)/At(-) and AtO(+)/At(+) couples have been determined, the respective values being 0.36 +/- 0.01 and 0.74 +/- 0.01 V vs NHE.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20014840     DOI: 10.1021/jp9077008

Source DB:  PubMed          Journal:  J Phys Chem A        ISSN: 1089-5639            Impact factor:   2.781


  6 in total

1.  Stability and in vivo behavior of Rh[16aneS4-diol]211 at complex: a potential precursor for astatine radiopharmaceuticals.

Authors:  Marek Pruszyński; Monika Łyczko; Aleksander Bilewicz; Michael R Zalutsky
Journal:  Nucl Med Biol       Date:  2014-12-23       Impact factor: 2.408

Review 2.  Astatine-211: production and availability.

Authors:  Michael R Zalutsky; Marek Pruszynski
Journal:  Curr Radiopharm       Date:  2011-07

3.  Radiopharmaceutical chemistry of targeted radiotherapeutics, part 4: Strategies for 211At labeling at high activities and radiation doses of 211At α-particles.

Authors:  Oscar R Pozzi; Michael R Zalutsky
Journal:  Nucl Med Biol       Date:  2016-12-10       Impact factor: 2.408

4.  Measurement of the first ionization potential of astatine by laser ionization spectroscopy.

Authors:  S Rothe; A N Andreyev; S Antalic; A Borschevsky; L Capponi; T E Cocolios; H De Witte; E Eliav; D V Fedorov; V N Fedosseev; D A Fink; S Fritzsche; L Ghys; M Huyse; N Imai; U Kaldor; Yuri Kudryavtsev; U Köster; J F W Lane; J Lassen; V Liberati; K M Lynch; B A Marsh; K Nishio; D Pauwels; V Pershina; L Popescu; T J Procter; D Radulov; S Raeder; M M Rajabali; E Rapisarda; R E Rossel; K Sandhu; M D Seliverstov; A M Sjödin; P Van den Bergh; P Van Duppen; M Venhart; Y Wakabayashi; K D A Wendt
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

5.  Targeted radionuclide therapy with astatine-211: Oxidative dehalogenation of astatobenzoate conjugates.

Authors:  David Teze; Dumitru-Claudiu Sergentu; Valentina Kalichuk; Jacques Barbet; David Deniaud; Nicolas Galland; Rémi Maurice; Gilles Montavon
Journal:  Sci Rep       Date:  2017-05-31       Impact factor: 4.379

6.  The electron affinity of astatine.

Authors:  David Leimbach; Julia Karls; Yangyang Guo; Rizwan Ahmed; Jochen Ballof; Lars Bengtsson; Ferran Boix Pamies; Anastasia Borschevsky; Katerina Chrysalidis; Ephraim Eliav; Dmitry Fedorov; Valentin Fedosseev; Oliver Forstner; Nicolas Galland; Ronald Fernando Garcia Ruiz; Camilo Granados; Reinhard Heinke; Karl Johnston; Agota Koszorus; Ulli Köster; Moa K Kristiansson; Yuan Liu; Bruce Marsh; Pavel Molkanov; Lukáš F Pašteka; João Pedro Ramos; Eric Renault; Mikael Reponen; Annie Ringvall-Moberg; Ralf Erik Rossel; Dominik Studer; Adam Vernon; Jessica Warbinek; Jakob Welander; Klaus Wendt; Shane Wilkins; Dag Hanstorp; Sebastian Rothe
Journal:  Nat Commun       Date:  2020-07-30       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.